Purchase Order 75N91024P00138
Award Date 12/20/23
Potential Completion Date 12/19/24
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price purchase order award by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) to Emulate Inc., doing business as Emulate, a for-profit organization. The contract is a Total Small Business Set-Aside with a potential value of $204,922.00 and a completion date of March 19, 2024. The award is based on a combined synopsis/solicitation for Emulate Bio Organ-On-AChip reagent kits. Emulate's organ-on-a-chip...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Emulate Inc., a for-profit small business organization. The contract, valued at $24,997.00, is for the delivery of biological kits and reagents, which are likely components of Emulate's organ-on-a-chip technology products used to model human biology. These products support the National Cancer Institute's initiatives in areas such as...
- This firm-fixed-price purchase order was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Emulate Inc. (doing business as Emulate) on June 1, 2020. The $130,163.45 contract, titled "EMULATE: ESTABLISHING ORGAN-CHIP MODELS FOR STUDYING RADIATION-INDUCED NORMAL TISSUE INJURY AND IDENTIFYING RNA BIOMARKERS FOR RADIATION BIODOSIMETRY," is for the development of an automated microfluidic cell culture system of human...
- This is a $142,686.37 firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Emulate Inc. (doing business as Emulate), a for-profit small business. The contract is for Emulate's human emulation organ-on-a-chip instruments and accessories, which support the National Institute of Neurological Disorders and Stroke's mission to develop in vitro 3D brain organoid models for studying neurological...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Emulate Inc., doing business as Emulate, a for-profit organization. The contract, valued at $205,554.00, is for an extended warranty and service agreement for Emulate's organ-on-a-chip technology, which models human biology for biomedical research. This requirement supports NIAID's Integrated...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order contract to Emulate Inc., doing business as Emulate, a for-profit organization. The $200,300.00 contract is for the provision of a human emulation system, which is a set-aside for small businesses. Emulate's organ-on-a-chip technology is designed to model human biology for biomedical research, supporting federal initiatives in areas like personalized medicine, biosurveillance,...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency within the Department of Health and Human Services, to Emulate Inc. for the trade-in of a Zoe Culture Module 2. The contract has a ceiling value of $180,800 and a completion date of September 16, 2024. Emulate Inc., a for-profit organization that develops organ-on-a-chip technology, has received prior contract and grant awards from various federal agencies,...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $217,700.00 firm-fixed-price purchase order contract to Emulate Inc., doing business as Emulate, a small business organization. The contract is for upgrades to the existing Zoe Culture Module Systems. This contract supports NIAID's initiatives in areas such as personalized medicine, biosurveillance, infectious disease research, and alternatives to animal testing. Emulate Inc. has provided a wide range of...
- This federal contract award, valued at $73,050.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Emulate Inc., a for-profit organization specializing in organ-on-a-chip technology. The award is for a Restricted Lab Service Program to provide four Zoe CM2 Culture Modules for Organ Chips. The contract is a Firm Fixed Price Purchase Order with a completion date of September 16, 2025. This award does not utilize a set-aside designation. Emulate Inc., also known...
- The Department of Health and Human Services' National Institutes of Health National Institute of Environmental Health Sciences awarded a $171,400 firm fixed price purchase order to Emulate Inc., doing business as Emulate, for the expansion of their ZOE microphysiological system. The place of performance will be Emulate's facilities in Research Triangle Park, North Carolina, and work is to be completed between September 14, 2023 and October 13, 2023. The associated sole source solicitation sought...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,616 purchase order to Emulate Inc., doing business as Emulate, located in Rockville, Maryland. The contract is for a one-year period starting December 20, 2023 through December 19, 2024 to provide a complete human emulation system as a service. No subcontractors or set aside designations were identified. The National Cancer Institute supports research to advance cancer prevention, detection, diagnosis, and treatment. This contract will support those efforts by providing access to Emulate's human tissue chip technology, allowing researchers to model complex human biology and diseases outside of live human and animal systems.
Generated 12/16/23, 5:41 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.6k | 12/15/23 |